Monday, June 29, 2009

BWI: GVK Biosciences Announces Agreement with University of Tokyo on GPCR Database

Press release from Business Wire India
Source: GVK Biosciences Private Limited
Monday, June 29, 2009 05:24 PM IST (11:54 AM GMT)
Editors: General: Consumer interest; Business: Advertising, PR & marketing, Business services, Education & training, Healthcare, biotechnology & pharmaceutical, Information technology; Technology; Healthcare
GVK Biosciences Announces Agreement with University of Tokyo on GPCR Database

Hyderabad, Andhra Pradesh, India, Monday, June 29, 2009 -- (Business Wire India) -- GVK Biosciences (GVK BIO) today announced that it has entered into an Agreement with Dr. Kimito Funatsu, University of Tokyo on its GPCR Databases. Dr. Kimito Funatsu, a world-renowned professor, teaches at University of Tokyo's prestigious Department of Chemical System Engineering.

The Agreement covers the GPCR class of targets curated at GVK BIO. Professor Kimito Funatsu will utilize the manually curated GPCR inhibitor database that contains over 1 million published and patented inhibitors and over 4 million quantitative structure-activity points, to develop advanced cheminformatics tools. Chemical Biological and Pharmacological Information of G protein-coupled receptors (GPCR) inhibitors from International Journals, US and International Patents have been curated to form this database which is available in various formats like in ISIS/Base DB, SD, XML and Oracle.

Prof. Kimito Funatsu heads the Funatsu Laboratory at University of Tokyo. He is also the Chairman of Chemical Information and Computer Sciences in The Chemical Society of Japan. The principal research theme of the Funatsu laboratory is Chemoinfomatics, which is the novel research area for solving various chemical problems by using technologies of information sciences.

GVK BIO is a leader in SAR, PK/Tox, Clinpharm and Biomarker databases manually curated from various journals, patents, clinical trials and literature. Apart from GPCR, GVK BIO has MedChem database and 9 other target inhibitor databases namely, Kinase, Protease, Ion-channel, NHR, Transporter, Phosphotase, Transferase, Lipase and Phosphodiesterases. MedChem Database has information from Medicinal Chemistry journals.

Sreeni Devidas, Vice President Business Development, GVK BIO commented: "We are honored to initiate this collaboration with Professor Kimito Funatsu. The efforts of the collaboration would result in the development of advanced cheminformatics tools that would utilize the vast amount of published and patented knowledge to further accelerate drug discovery".


GVK Biosciences Private Limited (GVK BIO) is Asia's leading Contract Research Organization and preferred partner of choice to 15 of the top 20 Big Pharma and 55 Biotech/Mid-pharma companies. Spread across multiple locations and headquartered at Hyderabad, India, GVK BIO employees 1500+ employees to assist our clients create new standards in healthcare.

Sreeni Devidas, Vice President - Business Development, GVK Biosciences Private Limited, 001-443-838-6260,
Sharada Alvakonda, Dy General Manager, Corporate Communications, GVK Biosciences Private Limited, +91 (40) 66929999,


If you wish to change your Business Wire India selection please click on this link and use your personal username and password to login.

Submit your press release at

No comments:

Post a Comment